We are live on
!
Find out more
ELC
Edgar Lomax Company Portfolio holdings
AUM
$1.4B
1-Year Est. Return
20.67%
This Fund
S&P 500
This Quarter
Est. Return
+15.37%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.65B
AUM Growth
+$201M
(+14%)
Cap. Flow
-$9.38M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
43.89%
Holding
59
New
–
Increased
1
Reduced
55
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$579K |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$571K |
| 3 |
Merck
MRK
|
+$520K |
| 4 |
General Dynamics
GD
|
+$462K |
| 5 |
CVS Health
CVS
|
+$461K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.47% |
| 2 | Financials | 17.54% |
| 3 | Industrials | 11.19% |
| 4 | Consumer Staples | 10.33% |
| 5 | Energy | 9.95% |
Similar funds
FCP
TWM
AI
IAS
EA
QC
SCM
SP
Edgar Lomax Company's Q4 2022 Portfolio in Review
As of Q4 2022, Edgar Lomax Company held 59 positions worth $1.65B, up 14% from $1.45B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 0%. Edgar Lomax Company opened no new positions and made no exits, leaving the 59-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Financials and Industrials.
- Edgar Lomax Company added most to iShares S&P 500 Value ETF in Q4 2022, an estimated $1.57M increase.
- Edgar Lomax Company's biggest Q4 2022 reduction was Verizon, cutting an estimated $579K.
- Edgar Lomax Company's ten largest holdings make up 44% of its $1.65B portfolio in Q4 2022.
- Edgar Lomax Company opened 0 new positions and closed 0 in Q4 2022.
- Edgar Lomax Company's portfolio value rose 14% quarter-over-quarter to $1.65B.
Based on Edgar Lomax Company's 13F filing for Q4 2022, filed 13 Feb 2023.